» Articles » PMID: 33435142

Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders

Overview
Publisher MDPI
Date 2021 Jan 13
PMID 33435142
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

NLRP3 inflammasome is one of the multimeric protein complexes of the nucleotide-binding domain, leucine-rich repeat (NLR)-containing pyrin and HIN domain family (PYHIN). When activated, NLRP3 inflammasome triggers the release of pro-inflammatory interleukins (IL)-1β and IL-18, an essential step in innate immune response; however, defective checkpoints in inflammasome activation may lead to autoimmune, autoinflammatory, and metabolic disorders. Among the consequences of NLRP3 inflammasome activation is systemic chronic low-grade inflammation, a cardinal feature of obesity and insulin resistance. Understanding the mechanisms involved in the regulation of NLRP3 inflammasome in adipose tissue may help in the development of specific inhibitors for the treatment and prevention of obesity-mediated metabolic diseases. In this narrative review, the current understanding of NLRP3 inflammasome activation and regulation is highlighted, including its putative roles in adipose tissue dysfunction and insulin resistance. Specific inhibitors of NLRP3 inflammasome activation which can potentially be used to treat metabolic disorders are also discussed.

Citing Articles

Probiotic, Postbiotic, and Paraprobiotic Effects of as a Modulator of Obesity-Associated Factors.

Lopez-Almada G, Mejia-Leon M, Salazar-Lopez N Foods. 2024; 13(22).

PMID: 39593945 PMC: 11592899. DOI: 10.3390/foods13223529.


Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism.

Mosalmanzadeh N, Pence B Int J Mol Sci. 2024; 25(21).

PMID: 39518939 PMC: 11545486. DOI: 10.3390/ijms252111386.


The AGEs/RAGE Signaling Pathway Regulates NLRP3-Mediated Neuronal Pyroptosis After MCAO Injury in Obese Rats.

Zhao L, Li S, Wang X, Zhang L, Zhang J, Liu X J Inflamm Res. 2024; 17:6935-6954.

PMID: 39372588 PMC: 11453143. DOI: 10.2147/JIR.S476458.


Trends and characteristics of the metabolically healthy obese phenotype in an Arab population.

Wani K, Kumar B, Al-Daghri N, Sabico S Front Public Health. 2024; 12:1371359.

PMID: 39145170 PMC: 11322095. DOI: 10.3389/fpubh.2024.1371359.


Inflammatory markers and noncoding-RNAs responses to low and high compressions of HIIT with or without berberine supplementation in middle-aged men with prediabetes.

Nikseresht M, Dabidi Roshan V, Nasiri K Physiol Rep. 2024; 12(15):e16146.

PMID: 39107107 PMC: 11303016. DOI: 10.14814/phy2.16146.


References
1.
Martine P, Rebe C . Heat Shock Proteins and Inflammasomes. Int J Mol Sci. 2019; 20(18). PMC: 6771073. DOI: 10.3390/ijms20184508. View

2.
Henao-Mejia J, Elinav E, Strowig T, Flavell R . Inflammasomes: far beyond inflammation. Nat Immunol. 2012; 13(4):321-4. DOI: 10.1038/ni.2257. View

3.
Rheinheimer J, de Souza B, Cardoso N, Bauer A, Crispim D . Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review. Metabolism. 2017; 74:1-9. DOI: 10.1016/j.metabol.2017.06.002. View

4.
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

5.
Labbe K, McIntire C, Doiron K, LeBlanc P, Saleh M . Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity. 2011; 35(6):897-907. DOI: 10.1016/j.immuni.2011.10.016. View